A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device

Supportive Care in Cancer

Volumn 15, Issue 1, 2007, Pages 95-99

  Cesaro, Simone ^a   Cavaliere, Mara ^a   Spiller, Monica ^a   Rossi, Lucia ^a   Magagna, Laura ^a   Gavin, Patrizia ^a   Bonetto, Michela ^a   Carli, Modesto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Broviac Hickman catheter; CLC 2000; Heparin; Lock therapy; Pediatric malignancy

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFTAZIDIME; HEPARIN; SODIUM CHLORIDE; TEICOPLANIN; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BRAIN TUMOR; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CORYNEBACTERIUM; FEMALE; FOLLOW UP; FUNGEMIA; HUMAN; INFECTION; MALE; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; NEUROBLASTOMA; NEUTROPENIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYREXIA IDIOPATHICA; RECURRENT DISEASE; STAPHYLOCOCCUS EPIDERMIDIS;

ADOLESCENT; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CORYNEBACTERIUM INFECTIONS; FEMALE; HUMANS; INFANT; MALE; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TEICOPLANIN; VANCOMYCIN;

EID: 33846170055     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0099-5     Document Type: Article

References (15)

1. Anthony TU, Rubin LG (1999) Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (Ports). Antimicrob Agents Chemother 43:2074-2077
2. Bouza E, Burillo A, Muñoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8:265-274
3. Carratalà J (2002) The antibiotic-lock technique for therapy of "highly needed" infected catheters. Clin Microbiol Infect 8:282-289
4. Cesaro S, Corrò R, Pelosin A et al (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183-188
5. Crnich CJ, Maki DG (2002) The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 34:1232-1242
6. Curtin J, Cormican M, Fleming G et al (2003) Linezolid compared with Eperezolid, Vancomycin, and Gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145-3148
7. Droste JC, Jeraj HA, MacDonald A et al (2003) Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 51:849-855
8. Fätkenheuer G, Cornely O, Seifert H (2002) Clinical management of catheter-related infections. Clin Microbiol Infect 8:545-550
9. Henrickson KJ, Axtell RA, Hoover SM et al (2000) Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 18:1269-1278
10. Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guideline for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751
11. Mermel LA, Farr MA, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272
12. Segarra-Newnham M, Martin-Cooper EM (2005) Antibiotic lock technique: a review of the literature. Ann Pharmacother 39:311-318
13. Vercaigne LM, Zelenitsky SA, Findlay I et al (2002) An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters. J Antimicrob Chemother 49:693-696
14. Warkentin TE, Levine MN, Hirsh J et al (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335
15. Wenzel RP, Edmond MB (2001) The impact of hospital-acquired blood-stream infections. Emerg Infect Dis 7(2):174-177